Eye on H1N1

7:24 PM ET Sun, 1 Nov 2009

Manufacturers are having issues with yields from strains used to produce H1N1 vaccines, says Rhenu Bhuller, global VP of pharmaceuticals at Frost & Sullivan. She sheds light on what is happening, with guest host, Greg Bundy of AIMS Finance & CNBC's Martin Soong.